Intratympanic steroid treatments rescued recurrent hearing loss following COVID-19 vaccination and detection of an intralabyrinthine schwannoma.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
06 Jul 2022
Historique:
entrez: 6 7 2022
pubmed: 7 7 2022
medline: 9 7 2022
Statut: epublish

Résumé

It remains unclear how to effectively treat rare cases of sudden and recurrent hearing losses which might coincidently follow vaccination. We report the first case, to our knowledge, of systemic and local steroid administration to successfully treat sudden and recurrent left-ear hearing loss, respectively, following a second dose of the BNT162b2 COVID-19 mRNA vaccination which inflammatory response potentially affected an existing left intralabyrinthine schwannoma in a young male patient. This case highlights the importance and timing of intratympanic steroid treatment strategies to suppress the progressive symptoms and restore hearing to a stable condition, and therefore avoid permanent hearing loss which would otherwise demand a surgical removal of the schwannoma to improve vertigo and reconstitute artificial hearing.

Identifiants

pubmed: 35793841
pii: 15/7/e249316
doi: 10.1136/bcr-2022-249316
pmc: PMC9260791
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0
Steroids 0
BNT162 Vaccine N38TVC63NU

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States

Informations de copyright

© BMJ Publishing Group Limited 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Acad Radiol. 2021 Nov;28(11):1530-1540
pubmed: 34548231
JAMA Otolaryngol Head Neck Surg. 2021 Jul 1;147(7):674-676
pubmed: 34014263
Int J Infect Dis. 2020 Aug;97:208-211
pubmed: 32535294
N Engl J Med. 2021 Oct 7;385(15):1393-1400
pubmed: 34525275
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Am J Otolaryngol. 2020 May - Jun;41(3):102487
pubmed: 32336572
Acta Otorhinolaryngol Ital. 2020 Dec;40(6):463-465
pubmed: 32519994

Auteurs

Weihang Li (W)

Aeronautical & Astronautical Engineering, Purdue University, West Lafayette, Indiana, USA.

Alan Micco (A)

Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Deyu Fang (D)

Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA huiping.liu@northwestern.edu fangd@northwestern.edu.

Huiping Liu (H)

Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA huiping.liu@northwestern.edu fangd@northwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH